Drug Shortage Report for ESCITALOPRAM
Report ID | 36040 |
Drug Identification Number | 02429047 |
Brand name | ESCITALOPRAM |
Common or Proper name | ESCITALOPRAM |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ESCITALOPRAM |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2017-12-15 |
Estimated end date | |
Actual end date | 2018-02-15 |
Shortage status | Resolved |
Updated date | 2018-02-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-02-16 | English | Compare |
v4 | 2018-01-30 | French | Compare |
v3 | 2018-01-30 | English | Compare |
v2 | 2018-01-16 | French | Compare |
v1 | 2018-01-16 | English | Compare |
Showing 1 to 5 of 5